-
ECG Helps Detect Cardiac Involvement in Sarcoidosis
17 Sep 2025 15:10 GMT
… study of patients with cutaneous sarcoidosis, ECG abnormalities identified all cases … .6%.
All patients with cardiac sarcoidosis had other extracutaneous manifestations.
IN … and small number of cardiac sarcoidosis cases. Additionally, variations in detection …
-
Foundation for Sarcoidosis Research Reacts to the Announcement of aTyr Pharma’s Phase 3 Clinical Trial Results
17 Sep 2025 14:01 GMT
… patient quality of life. About Sarcoidosis
Sarcoidosis is a rare inflammatory disease … . Despite advances in research, sarcoidosis remains challenging to diagnose, with … the Foundation for Sarcoidosis Research
The Foundation for Sarcoidosis Research (FSR) …
-
aTyr Pharma stock crashes on Phase III pulmonary sarcoidosis fail
16 Sep 2025 13:03 GMT
… forward for efzofitimod in pulmonary sarcoidosis.
Dr Sanjay S. Shukla, president … that patients with chronic, symptomatic sarcoidosis can be managed with substantially … enrolled 268 patients with pulmonary sarcoidosis, evaluating the efficacy and safety …
-
aTyr Pharma Reports Positive Topline Results from Phase 3 Efzofitimod Sarcoidosis Trial
16 Sep 2025 11:59 GMT
… improvement in the King’s Sarcoidosis Questionnaire (KSQ)-Lung score … of quality of life in sarcoidosis. Additionally, a responder analysis … the next steps.”
Pulmonary sarcoidosis is a serious form … largest interventional trial in sarcoidosis to date. He noted …
-
<![CDATA[Efzofitimod Fails to Meet Primary End Point in Phase 3 Pulmonary Sarcoidosis Trial]]>
16 Sep 2025 02:33 GMT
… weeks in people with pulmonary sarcoidosis although clinical benefits were … largest interventional study completed in sarcoidosis to date, demonstrating the feasibility … that patients with chronic, symptomatic sarcoidosis can be managed with substantially …
-
aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis
15 Sep 2025 11:30 GMT
… largest interventional study completed in sarcoidosis to date, demonstrating the … the event. About Pulmonary Sarcoidosis Pulmonary sarcoidosis is an inflammatory disease … development of efzofitimod in pulmonary sarcoidosis; and certain development goals. …
-
Understanding sarcoidosis: From mild cases to life-threatening complications
13 Sep 2025 02:08 GMT
… be at risk of progressive sarcoidosis.
Sarcoidosis occurs when the immune … discovered during routine medical examinations.Sarcoidosis lung involvement and pulmonary … commonly affected organs in sarcoidosis. Pulmonary sarcoidosis can cause persistent cough …
-
Temple University Hospital highlights sarcoidosis care in collaboration with 6abc
25 Aug 2025 07:15 GMT
… . Rohit Gupta, Director of the Sarcoidosis Program at Temple University Hospital … . Rohit Gupta, Director of the Sarcoidosis Program at Temple University Hospital … , discussing how specialized treatment keeps sarcoidosis under control. The segment also …
-
Methotrexate Matches Prednisone in Pulmonary Sarcoidosis Treatment Efficacy: Study
01 Aug 2025 22:26 GMT
… first-line option for pulmonary sarcoidosis. The distinct AE profiles highlight … First-line Treatment for Pulmonary Sarcoidosis: The PREDMETH Trial [abstract]. … .A1007
Keywords:
methotrexate, prednisone, pulmonary sarcoidosis, FVC, adverse events, first-line …
-
Ventricular Arrhythmias in Sarcoidosis Linked to Triple Mortality Risk and Higher Device Implantation Rates: Study
31 Jul 2025 04:23 GMT
… monitoring of ventricular arrhythmias in sarcoidosis patients. Timely identification and … and prevent severe cardiac complications.
Sarcoidosis, an inflammatory disease that … a major prognostic factor in sarcoidosis, associated with significantly higher …